Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients

Inflammatory Bowel Diseases
Pengguang YanJingnan Li

Abstract

Carcinogenesis is a severe consequence of chronic ulcerative colitis. We investigated the somatic mutations and pathway alterations in ulcerative colitis-associated colorectal cancer (CRC) in Chinese patients compared with sporadic CRCs to reveal potential therapeutic targets in ulcerative colitis-associated CRC. Whole exome sequencing was performed on archival tumor tissues and paired adjacent nondysplastic mucosa from 10 ulcerative colitis-associated CRC patients at a high risk of carcinogenesis. Genomic alteration profiles from 223 primary CRCs from The Cancer Genome Atlas served as sporadic CRC controls. A meta-analysis was performed to investigate differences in major genetic mutations between ulcerative colitis-associated and Crohn's disease-associated CRCs. We identified 44 nonsilent recurrent somatic mutations via whole exome sequencing, including 25 deleterious mutations involved in apoptosis and the PI3K-Akt pathway (COL6A3, FN1), autophagy (ULK1), cell adhesion (PODXL, PTPRT, ZFHX4), and epigenetic regulation (ARID1A, NCOR2, KMT2D, NCOA6, MECP2, SUPT6H). In total, 11 of the 25 mutated genes significantly differed between ulcerative colitis-associated CRC and sporadic CRC (APC, APOB, MECP2, NCOR2, NTRK2, PODXL, RABGAP...Continue Reading

References

Dec 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·V Fernández-MajadaA Bigas
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takehiro KukitsuYoshiro Niitsu
Sep 18, 2010·Inflammatory Bowel Diseases·Toshiaki WatanabeUNKNOWN Japanese Society for Cancer of the Colon and Rectum
May 28, 2011·Inflammatory Bowel Diseases·Julian A SanchezMatthew F Kalady
Dec 20, 2011·Gastroenterology·Susan GalandiukTrevor A Graham
Nov 20, 2012·Seminars in Immunopathology·Sergei I Grivennikov
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
May 1, 2013·Genes & Development·Adrienne MottisJohan Auwerx
Aug 15, 2013·Cancer Letters·Gerhard Rogler
Jun 18, 2014·Epigenetics : Official Journal of the DNA Methylation Society·R Alan HarrisRichard Kellermayer
Dec 4, 2014·World Journal of Gastroenterology : WJG·Masakazu Yashiro
Apr 5, 2015·Digestive Diseases and Sciences·Masakazu Yashiro
Nov 12, 2015·World Journal of Gastroenterology : WJG·Lauren Van Der KraakNicole Beauchemin
Jan 15, 2016·Gastroenterology·Ana I RoblesNickolas Papadopoulos
Dec 13, 2016·Nature Genetics·Radhika MathurCharles W M Roberts
Jan 17, 2017·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Deborah SaraggiMassimo Rugge
Feb 9, 2017·Nature Reviews. Gastroenterology & Hepatology·Chang-Ho R ChoiTrevor A Graham
May 20, 2017·British Journal of Cancer·Sanjiban ChakrabartyKapaettu Satyamoorthy
Jul 4, 2017·Gene·Eugene FroimchukKai Ge
Aug 18, 2017·United European Gastroenterology Journal·Sawan BopannaVineet Ahuja
Nov 4, 2017·Cell Death and Differentiation·Evan H BaughChang S Chan
May 10, 2018·Molecular Cancer Research : MCR·Huda H Al-Khalaf, Abdelilah Aboussekhra
Jul 4, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniela HirschTimo Gaiser
Jul 12, 2018·Gut·Ann-Marie BakerTrevor A Graham
Jan 1, 2018·Cell Death and Differentiation·Evan H BaughChang S Chan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.